0

Tag: diabetes

5 Cardiometabolic Health Topics You Can’t Miss at CMHC West 2019

With dozens of recently released revised clinical guidelines, breakthrough trial data, and newly approved drugs on the market, it is increasingly important for clinicians leading the fight against cardiometabolic disease to review the latest topics and industry developments. Explore how the most respected leaders of the industry are advancing cardiometabolic health and combating the growing epidemic of cardiovascular diseases through sessions spotlighting the most recent and relevant research.

Cardiovascular Disease
The American Heart Association estimates that someone dies of cardiovascular disease every 38 seconds, leaving CVD as the leading cause of death in the United States. Recent advances in cardiovascular medicine continue to address the problem, with greater usage of direct oral anticoagulants, new paradigms in mitral valve regurgitation management and a larger emphasis on technological devices playing a leading role in the ongoing battle against CVD.

New research reveals a correlation between diabetes and increased risk of cardiovascular and thrombotic adverse events in patients with CAD, PAD, and AF, suggesting that current antithrombotic strategies may need to be reevaluated. Learn more at the Antithrombotics in Diabetic Patients: Recent Clinical Trial Results session chaired by Deepak L. Bhatt, MD.

Obesity Management
In 2019, obesity stands as the second most prevalent CVD risk factor in the United States. The alarming rise in worldwide obesity paralleled with the increased incidence of type 2 diabetes mellitus suggests the need for impactful obesity management in the population.

As awareness of obesity complications grows, the focus turns to obesity management techniques such as tailoring nutritional plans specific to patients and their needs. Recent research on the benefits of bariatric surgery for cardiometabolic patients and its long-term effects will be presented alongside developments in pharmacotherapy for obese patients and lifestyle medicine. Learn more from world-renowned experts Dr. Robert E. Ratner and Dr. Ken Fujioka at Session I: Obesity and Lifestyle Medicine .

Heart Failure
The incidence of heart failure is the only form of heart disease that hasn’t decreased in over 30 years, with approximately 550,000 new cases diagnosed in the U.S. per year.  Technological advancements in cardiac devices and improved prevention and treatment methods have diminished the death rate, but cardiovascular disease remains the leading cause of death in the country. A growing need to identify the underlying metabolic causes of heart failure prompts new studies aimed at developing new therapies for patients and addressing the problem at its earliest stage.

Recent research points to the need for comprehensive therapeutic strategies targeting heart failure and type 2 diabetes to improve overall patient outcomes. Studies have revealed that antihyperglycemic therapy can prevent heart failure in patients with and without type 2 diabetes and can be used as a tool for optimizing HF patient care. Learn more about the connection between heart failure and diabetes, the latest advances in iron repletion therapy, and the most recent, relevant clinical research at Session III: Heart Failure and Hypertension .

Female Cardiometabolic Care
Cardiovascular disease is the leading cause of death in women, outnumbering deaths from all other causes combined. According to the American Heart Association, one in three women have some form of cardiovascular disease and recognizing women at risk of CVD is of tremendous public health importance. Studies have shown that under-recognition of heart disease in female patients is frequent and often leads to less aggressive treatment strategies and poorer outcomes. Comprehensive education, training,and awareness are necessary to ensure adequate future female cardiometabolic care.

Back by popular demand, the CMHC West Women’s Health Summit will cover an array of topics ranging from the intersection between breast cancer and CVD, to cardiometabolic risk in American Indians, Alaska native women, pregnancy and PCOS patients. The one-day workshop spearheaded by Dr. Pamela Morris, expert on female cardiovascular risk, will present an in-depth analysis of the intricacies related to female cardiometabolic care and the newest developments in prevention and management therapy. Explore the Women’s Health Summit agenda, the can’t-miss event in women’s healthcare of the year.

Diabetes Management
According to recent calculations, the CDC reports 100 million U.S. adults to be living with diabetes or prediabetes, with that number expected to rise to 592 million by 2035.
Only about 20% of diabetic individuals are under professional care, according to BioMed Central. A recent study on the future implications of diabetes projects that the condition will remain a major health crisis in America despite medical advances and prevention efforts.

Crucial to the control of this epidemic is successful diabetes management based on the most recent research and trial results. Adherence to new glycemic target guidelines, medication and treatment plans and the impact of real-world data on the treatment of patients with T2DM will be discussed in depth by expert faculty with decades of experience in diabetic care. Learn more about the newest developments in diabetic therapies, prevention, and management at Session IV: Diabetes Management.

CMHC West 2019: Advancing Cardiometabolic Health from East to West
The CMHC West conference allows attendees the opportunity to delve into three days of comprehensive clinical education, covering the key topics below, led by world-renowned faculty, clinicians and keynote speakers and guaranteed to leave attendees with the most up-to-date, applicable knowledge to incorporate into their practice.

You can still gain access to the latest clinical education and a panel of world-renowned speakers by signing up today for our can’t miss event in cardiometabolic health education.

Register Now 

Diabetes Management in the Digital Age

With increasing smartphone and digital device usage, there is a growing opportunity for technological tools to be incorporated into diabetes self-management (DSME). Although studies are limited thus far, scientific advancements in diabetes care have reduced long-term complications by improving glucose control, and simplifying disease management. Poor glucose control can lead to long-term diabetes, micro- and macro-vascular complications, and other health issues: all of which generate higher morbidity and mortality rates. The CDC reports that 100 million U.S. adults live with diabetes or prediabetes: a number expected to rise to 592 million by 2035.

Only about 20% of diabetic individuals are under professional care, according to an article from BioMed Central, and 77% of people with diabetes live in low- to mid-income countries with a lack of resources for adequate diabetes self-management training: an essential component of preventing long-term complications. There is both an opportunity and need for the development of cost-effective tools to support DSME in order to improve overall diabetes outcomes, particularly in developing countries. The increase of smartphone and digital device users has influenced the rise of mobile app technology, designed to help patients manage their diabetes. Applications that monitor food intake, physical activity, medication adherence, blood glucose levels and insulin doses are designed to assist patients with daily management of their condition. Other helpful tools such as diabetes education platforms as well as relaxation and meditation apps are also becoming increasingly available.

Diabetes self-management training is tailored to people with or at risk for diabetes, and allows them to gain the knowledge and skills necessary to successfully manage the condition. This includes information on healthy eating, self-monitoring of blood sugar levels (SMBG), medication adherence, and other risk-reduction behaviors. Not only has DSME proven effective in lowering A1c and blood pressure levels, it is also cost-effective. DSME training support is becoming more widely available to patients through online education materials provided by government organizations, professional organizations such as the American Diabetes Association, and nonprofits.

As weight management is crucial to the prevention of long-term diabetes complications, conducted studies have revealed a marked increase in weight loss results with the use of monitoring apps. Nutrition trackers and other healthy eating applications—such as Healthy Out, Foodily, and CarbControl—offer features to assist with meal planning and weight management. Extensive nutritional information, calorie and food trackers, and personalized diet plans can help modify behaviors while controlling blood glucose levels: all from a smartphone device. Readily available physical activity tracking applications, including MyFitnessPal and Endomondo, allow users to monitor activity levels, count calories, and set targeted goals for weight management.

Specifically designed blood glucose monitoring applications and insulin dose calculators are additional technological advancements that assist with daily self-management. Patients prescribed multiple daily insulin injections are recommended to check blood glucose levels at least three times a day, which can prove bothersome due to bulky devices, frequent blood drawing, and manual result logging. Apps such as EasyDose, Insulin RX, and Glucose aim to simplify the process of SMBG levels and calculate accurate insulin doses while increasing patient compliance rate.

Medication non-adherence is another recurring issue with diabetes patients, resulting in poor glycemic control and increased risk of long-term complications. MyMedSchedule, MedSimple, and other applications developed to solve this problem are simple and cost-effective, reminding patients to take medication, and thus improve overall glycemic results.

These new developments in DMSE technology have additionally increased the amount of data available to healthcare professionals, giving them enhanced access to reliable information, and allowing them to effectively support patient care. The expansions in diabetes technology provide exciting opportunities in health care for both patients and physicians seeking more effective care management. While robust data on the benefits of these health-related apps is still lacking, small-scale studies have demonstrated better glucose control, improved SMBG outcomes, and enhanced medication adherence. The future of digital diabetes management is promising; further studies on the benefits of digital technology with larger randomized control trials are underway, and the development of technological applications and digital devices continues.